img

Global Next Generation Sequencing (NGS) Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Next Generation Sequencing (NGS) Market Insights, Forecast to 2034

Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.
Market Analysis and InsightsGlobal Next Generation Sequencing (NGS) Market
Global Next Generation Sequencing (NGS) market is expected to reach to US$ 3834.5 million in 2023, with a positive growth of %, compared with US$ 3690.2 million in 2022. Backed with the increasing demand from downstream industries, Next Generation Sequencing (NGS) industry is evaluated to reach US$ 4686.3 million in 2033. The CAGR will be 3.4% during 2023 to 2033.
The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.
Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.
North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.
Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.
Report Covers
This report presents an overview of global Next Generation Sequencing (NGS) market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Next Generation Sequencing (NGS) market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Illumina
Thermo Fisher Scientific
Pacific Biosciences of California
Beijing Genomics Institute
Qiagen
Roche
Agilent Technologies
Perkinelmer
Genomatix
PierianDx
Eurofins Scientific
Gatc Biotech
Oxford Nanopore Technologies
Bio-Rad Laboratories
DNASTAR
Biomatters
Partek
New England Biolabs
Myriad Genetics
Macrogen
Segment by Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing

Segment by Application


Academic & Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals & Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Next Generation Sequencing (NGS) introduction, etc. Next Generation Sequencing (NGS) Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Next Generation Sequencing (NGS)
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Sequencing (NGS) Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Targeted Sequencing
1.2.3 Whole Exome Sequencing
1.2.4 Whole Genome Sequencing
1.3 Market by Application
1.3.1 Global Next Generation Sequencing (NGS) Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Academic & Government Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Hospitals & Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Sequencing (NGS) Market Perspective (2018-2033)
2.2 Global Next Generation Sequencing (NGS) Growth Trends by Region
2.2.1 Next Generation Sequencing (NGS) Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Next Generation Sequencing (NGS) Historic Market Size by Region (2018-2023)
2.2.3 Next Generation Sequencing (NGS) Forecasted Market Size by Region (2024-2033)
2.3 Next Generation Sequencing (NGS) Market Dynamics
2.3.1 Next Generation Sequencing (NGS) Industry Trends
2.3.2 Next Generation Sequencing (NGS) Market Drivers
2.3.3 Next Generation Sequencing (NGS) Market Challenges
2.3.4 Next Generation Sequencing (NGS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Next Generation Sequencing (NGS) by Players
3.1.1 Global Next Generation Sequencing (NGS) Revenue by Players (2018-2023)
3.1.2 Global Next Generation Sequencing (NGS) Revenue Market Share by Players (2018-2023)
3.2 Global Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Next Generation Sequencing (NGS), Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Next Generation Sequencing (NGS) Market Concentration Ratio
3.4.1 Global Next Generation Sequencing (NGS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing (NGS) Revenue in 2022
3.5 Global Key Players of Next Generation Sequencing (NGS) Head office and Area Served
3.6 Global Key Players of Next Generation Sequencing (NGS), Product and Application
3.7 Global Key Players of Next Generation Sequencing (NGS), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Sequencing (NGS) Breakdown Data by Type
4.1 Global Next Generation Sequencing (NGS) Historic Market Size by Type (2018-2023)
4.2 Global Next Generation Sequencing (NGS) Forecasted Market Size by Type (2024-2033)
5 Next Generation Sequencing (NGS) Breakdown Data by Application
5.1 Global Next Generation Sequencing (NGS) Historic Market Size by Application (2018-2023)
5.2 Global Next Generation Sequencing (NGS) Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Next Generation Sequencing (NGS) Market Size (2018-2033)
6.2 North America Next Generation Sequencing (NGS) Market Size by Type
6.2.1 North America Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
6.2.2 North America Next Generation Sequencing (NGS) Market Size by Type (2024-2033)
6.2.3 North America Next Generation Sequencing (NGS) Market Share by Type (2018-2033)
6.3 North America Next Generation Sequencing (NGS) Market Size by Application
6.3.1 North America Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
6.3.2 North America Next Generation Sequencing (NGS) Market Size by Application (2024-2033)
6.3.3 North America Next Generation Sequencing (NGS) Market Share by Application (2018-2033)
6.4 North America Next Generation Sequencing (NGS) Market Size by Country
6.4.1 North America Next Generation Sequencing (NGS) Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Next Generation Sequencing (NGS) Market Size by Country (2018-2023)
6.4.3 North America Next Generation Sequencing (NGS) Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Next Generation Sequencing (NGS) Market Size (2018-2033)
7.2 Europe Next Generation Sequencing (NGS) Market Size by Type
7.2.1 Europe Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
7.2.2 Europe Next Generation Sequencing (NGS) Market Size by Type (2024-2033)
7.2.3 Europe Next Generation Sequencing (NGS) Market Share by Type (2018-2033)
7.3 Europe Next Generation Sequencing (NGS) Market Size by Application
7.3.1 Europe Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
7.3.2 Europe Next Generation Sequencing (NGS) Market Size by Application (2024-2033)
7.3.3 Europe Next Generation Sequencing (NGS) Market Share by Application (2018-2033)
7.4 Europe Next Generation Sequencing (NGS) Market Size by Country
7.4.1 Europe Next Generation Sequencing (NGS) Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Next Generation Sequencing (NGS) Market Size by Country (2018-2023)
7.4.3 Europe Next Generation Sequencing (NGS) Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Next Generation Sequencing (NGS) Market Size (2018-2033)
8.2 China Next Generation Sequencing (NGS) Market Size by Type
8.2.1 China Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
8.2.2 China Next Generation Sequencing (NGS) Market Size by Type (2024-2033)
8.2.3 China Next Generation Sequencing (NGS) Market Share by Type (2018-2033)
8.3 China Next Generation Sequencing (NGS) Market Size by Application
8.3.1 China Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
8.3.2 China Next Generation Sequencing (NGS) Market Size by Application (2024-2033)
8.3.3 China Next Generation Sequencing (NGS) Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Next Generation Sequencing (NGS) Market Size (2018-2033)
9.2 Asia Next Generation Sequencing (NGS) Market Size by Type
9.2.1 Asia Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
9.2.2 Asia Next Generation Sequencing (NGS) Market Size by Type (2024-2033)
9.2.3 Asia Next Generation Sequencing (NGS) Market Share by Type (2018-2033)
9.3 Asia Next Generation Sequencing (NGS) Market Size by Application
9.3.1 Asia Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
9.3.2 Asia Next Generation Sequencing (NGS) Market Size by Application (2024-2033)
9.3.3 Asia Next Generation Sequencing (NGS) Market Share by Application (2018-2033)
9.4 Asia Next Generation Sequencing (NGS) Market Size by Region
9.4.1 Asia Next Generation Sequencing (NGS) Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Next Generation Sequencing (NGS) Market Size by Region (2018-2023)
9.4.3 Asia Next Generation Sequencing (NGS) Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Next Generation Sequencing (NGS) Introduction
11.1.4 Illumina Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.1.5 Illumina Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Introduction
11.2.4 Thermo Fisher Scientific Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Pacific Biosciences of California
11.3.1 Pacific Biosciences of California Company Details
11.3.2 Pacific Biosciences of California Business Overview
11.3.3 Pacific Biosciences of California Next Generation Sequencing (NGS) Introduction
11.3.4 Pacific Biosciences of California Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.3.5 Pacific Biosciences of California Recent Developments
11.4 Beijing Genomics Institute
11.4.1 Beijing Genomics Institute Company Details
11.4.2 Beijing Genomics Institute Business Overview
11.4.3 Beijing Genomics Institute Next Generation Sequencing (NGS) Introduction
11.4.4 Beijing Genomics Institute Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.4.5 Beijing Genomics Institute Recent Developments
11.5 Qiagen
11.5.1 Qiagen Company Details
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Next Generation Sequencing (NGS) Introduction
11.5.4 Qiagen Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.5.5 Qiagen Recent Developments
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Next Generation Sequencing (NGS) Introduction
11.6.4 Roche Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.6.5 Roche Recent Developments
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Details
11.7.2 Agilent Technologies Business Overview
11.7.3 Agilent Technologies Next Generation Sequencing (NGS) Introduction
11.7.4 Agilent Technologies Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.7.5 Agilent Technologies Recent Developments
11.8 Perkinelmer
11.8.1 Perkinelmer Company Details
11.8.2 Perkinelmer Business Overview
11.8.3 Perkinelmer Next Generation Sequencing (NGS) Introduction
11.8.4 Perkinelmer Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.8.5 Perkinelmer Recent Developments
11.9 Genomatix
11.9.1 Genomatix Company Details
11.9.2 Genomatix Business Overview
11.9.3 Genomatix Next Generation Sequencing (NGS) Introduction
11.9.4 Genomatix Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.9.5 Genomatix Recent Developments
11.10 PierianDx
11.10.1 PierianDx Company Details
11.10.2 PierianDx Business Overview
11.10.3 PierianDx Next Generation Sequencing (NGS) Introduction
11.10.4 PierianDx Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.10.5 PierianDx Recent Developments
11.11 Eurofins Scientific
11.11.1 Eurofins Scientific Company Details
11.11.2 Eurofins Scientific Business Overview
11.11.3 Eurofins Scientific Next Generation Sequencing (NGS) Introduction
11.11.4 Eurofins Scientific Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.11.5 Eurofins Scientific Recent Developments
11.12 Gatc Biotech
11.12.1 Gatc Biotech Company Details
11.12.2 Gatc Biotech Business Overview
11.12.3 Gatc Biotech Next Generation Sequencing (NGS) Introduction
11.12.4 Gatc Biotech Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.12.5 Gatc Biotech Recent Developments
11.13 Oxford Nanopore Technologies
11.13.1 Oxford Nanopore Technologies Company Details
11.13.2 Oxford Nanopore Technologies Business Overview
11.13.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Introduction
11.13.4 Oxford Nanopore Technologies Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.13.5 Oxford Nanopore Technologies Recent Developments
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Next Generation Sequencing (NGS) Introduction
11.14.4 Bio-Rad Laboratories Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.14.5 Bio-Rad Laboratories Recent Developments
11.15 DNASTAR
11.15.1 DNASTAR Company Details
11.15.2 DNASTAR Business Overview
11.15.3 DNASTAR Next Generation Sequencing (NGS) Introduction
11.15.4 DNASTAR Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.15.5 DNASTAR Recent Developments
11.16 Biomatters
11.16.1 Biomatters Company Details
11.16.2 Biomatters Business Overview
11.16.3 Biomatters Next Generation Sequencing (NGS) Introduction
11.16.4 Biomatters Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.16.5 Biomatters Recent Developments
11.17 Partek
11.17.1 Partek Company Details
11.17.2 Partek Business Overview
11.17.3 Partek Next Generation Sequencing (NGS) Introduction
11.17.4 Partek Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.17.5 Partek Recent Developments
11.18 New England Biolabs
11.18.1 New England Biolabs Company Details
11.18.2 New England Biolabs Business Overview
11.18.3 New England Biolabs Next Generation Sequencing (NGS) Introduction
11.18.4 New England Biolabs Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.18.5 New England Biolabs Recent Developments
11.19 Myriad Genetics
11.19.1 Myriad Genetics Company Details
11.19.2 Myriad Genetics Business Overview
11.19.3 Myriad Genetics Next Generation Sequencing (NGS) Introduction
11.19.4 Myriad Genetics Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.19.5 Myriad Genetics Recent Developments
11.20 Macrogen
11.20.1 Macrogen Company Details
11.20.2 Macrogen Business Overview
11.20.3 Macrogen Next Generation Sequencing (NGS) Introduction
11.20.4 Macrogen Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.20.5 Macrogen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Next Generation Sequencing (NGS) Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Targeted Sequencing
Table 3. Key Players of Whole Exome Sequencing
Table 4. Key Players of Whole Genome Sequencing
Table 5. Global Next Generation Sequencing (NGS) Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Next Generation Sequencing (NGS) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Next Generation Sequencing (NGS) Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Next Generation Sequencing (NGS) Market Share by Region (2018-2023)
Table 9. Global Next Generation Sequencing (NGS) Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Next Generation Sequencing (NGS) Market Share by Region (2024-2033)
Table 11. Next Generation Sequencing (NGS) Market Trends
Table 12. Next Generation Sequencing (NGS) Market Drivers
Table 13. Next Generation Sequencing (NGS) Market Challenges
Table 14. Next Generation Sequencing (NGS) Market Restraints
Table 15. Global Next Generation Sequencing (NGS) Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Next Generation Sequencing (NGS) Revenue Share by Players (2018-2023)
Table 17. Global Top Next Generation Sequencing (NGS) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Sequencing (NGS) as of 2022)
Table 18. Global Next Generation Sequencing (NGS) Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Next Generation Sequencing (NGS) Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Next Generation Sequencing (NGS), Headquarters and Area Served
Table 21. Global Key Players of Next Generation Sequencing (NGS), Product and Application
Table 22. Global Key Players of Next Generation Sequencing (NGS), Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Next Generation Sequencing (NGS) Revenue Market Share by Type (2018-2023)
Table 26. Global Next Generation Sequencing (NGS) Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Next Generation Sequencing (NGS) Revenue Market Share by Type (2024-2033)
Table 28. Global Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Next Generation Sequencing (NGS) Revenue Share by Application (2018-2023)
Table 30. Global Next Generation Sequencing (NGS) Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Next Generation Sequencing (NGS) Revenue Share by Application (2024-2033)
Table 32. North America Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Next Generation Sequencing (NGS) Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Next Generation Sequencing (NGS) Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Next Generation Sequencing (NGS) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Next Generation Sequencing (NGS) Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Next Generation Sequencing (NGS) Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Next Generation Sequencing (NGS) Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Next Generation Sequencing (NGS) Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Next Generation Sequencing (NGS) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Next Generation Sequencing (NGS) Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Next Generation Sequencing (NGS) Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Next Generation Sequencing (NGS) Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Next Generation Sequencing (NGS) Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Next Generation Sequencing (NGS) Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Next Generation Sequencing (NGS) Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Next Generation Sequencing (NGS) Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Next Generation Sequencing (NGS) Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Next Generation Sequencing (NGS) Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size by Country (2024-2033) & (US$ Million)
Table 64. Illumina Company Details
Table 65. Illumina Business Overview
Table 66. Illumina Next Generation Sequencing (NGS) Product
Table 67. Illumina Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 68. Illumina Recent Developments
Table 69. Thermo Fisher Scientific Company Details
Table 70. Thermo Fisher Scientific Business Overview
Table 71. Thermo Fisher Scientific Next Generation Sequencing (NGS) Product
Table 72. Thermo Fisher Scientific Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 73. Thermo Fisher Scientific Recent Developments
Table 74. Pacific Biosciences of California Company Details
Table 75. Pacific Biosciences of California Business Overview
Table 76. Pacific Biosciences of California Next Generation Sequencing (NGS) Product
Table 77. Pacific Biosciences of California Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 78. Pacific Biosciences of California Recent Developments
Table 79. Beijing Genomics Institute Company Details
Table 80. Beijing Genomics Institute Business Overview
Table 81. Beijing Genomics Institute Next Generation Sequencing (NGS) Product
Table 82. Beijing Genomics Institute Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 83. Beijing Genomics Institute Recent Developments
Table 84. Qiagen Company Details
Table 85. Qiagen Business Overview
Table 86. Qiagen Next Generation Sequencing (NGS) Product
Table 87. Qiagen Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 88. Qiagen Recent Developments
Table 89. Roche Company Details
Table 90. Roche Business Overview
Table 91. Roche Next Generation Sequencing (NGS) Product
Table 92. Roche Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 93. Roche Recent Developments
Table 94. Agilent Technologies Company Details
Table 95. Agilent Technologies Business Overview
Table 96. Agilent Technologies Next Generation Sequencing (NGS) Product
Table 97. Agilent Technologies Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 98. Agilent Technologies Recent Developments
Table 99. Perkinelmer Company Details
Table 100. Perkinelmer Business Overview
Table 101. Perkinelmer Next Generation Sequencing (NGS) Product
Table 102. Perkinelmer Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 103. Perkinelmer Recent Developments
Table 104. Genomatix Company Details
Table 105. Genomatix Business Overview
Table 106. Genomatix Next Generation Sequencing (NGS) Product
Table 107. Genomatix Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 108. Genomatix Recent Developments
Table 109. PierianDx Company Details
Table 110. PierianDx Business Overview
Table 111. PierianDx Next Generation Sequencing (NGS) Product
Table 112. PierianDx Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 113. PierianDx Recent Developments
Table 114. Eurofins Scientific Company Details
Table 115. Eurofins Scientific Business Overview
Table 116. Eurofins Scientific Next Generation Sequencing (NGS) Product
Table 117. Eurofins Scientific Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 118. Eurofins Scientific Recent Developments
Table 119. Gatc Biotech Company Details
Table 120. Gatc Biotech Business Overview
Table 121. Gatc Biotech Next Generation Sequencing (NGS) Product
Table 122. Gatc Biotech Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 123. Gatc Biotech Recent Developments
Table 124. Oxford Nanopore Technologies Company Details
Table 125. Oxford Nanopore Technologies Business Overview
Table 126. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Product
Table 127. Oxford Nanopore Technologies Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 128. Oxford Nanopore Technologies Recent Developments
Table 129. Bio-Rad Laboratories Company Details
Table 130. Bio-Rad Laboratories Business Overview
Table 131. Bio-Rad Laboratories Next Generation Sequencing (NGS) Product
Table 132. Bio-Rad Laboratories Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 133. Bio-Rad Laboratories Recent Developments
Table 134. DNASTAR Company Details
Table 135. DNASTAR Business Overview
Table 136. DNASTAR Next Generation Sequencing (NGS) Product
Table 137. DNASTAR Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 138. DNASTAR Recent Developments
Table 139. Biomatters Company Details
Table 140. Biomatters Business Overview
Table 141. Biomatters Next Generation Sequencing (NGS) Product
Table 142. Biomatters Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 143. Biomatters Recent Developments
Table 144. Partek Company Details
Table 145. Partek Business Overview
Table 146. Partek Next Generation Sequencing (NGS) Product
Table 147. Partek Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 148. Partek Recent Developments
Table 149. New England Biolabs Company Details
Table 150. New England Biolabs Business Overview
Table 151. New England Biolabs Next Generation Sequencing (NGS) Product
Table 152. New England Biolabs Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 153. New England Biolabs Recent Developments
Table 154. Myriad Genetics Company Details
Table 155. Myriad Genetics Business Overview
Table 156. Myriad Genetics Next Generation Sequencing (NGS) Product
Table 157. Myriad Genetics Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 158. Myriad Genetics Recent Developments
Table 159. Macrogen Company Details
Table 160. Macrogen Business Overview
Table 161. Macrogen Next Generation Sequencing (NGS) Product
Table 162. Macrogen Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 163. Macrogen Recent Developments
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next Generation Sequencing (NGS) Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Next Generation Sequencing (NGS) Market Share by Type: 2022 VS 2033
Figure 3. Targeted Sequencing Features
Figure 4. Whole Exome Sequencing Features
Figure 5. Whole Genome Sequencing Features
Figure 6. Global Next Generation Sequencing (NGS) Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Next Generation Sequencing (NGS) Market Share by Application: 2022 VS 2033
Figure 8. Academic & Government Research Institutes Case Studies
Figure 9. Pharmaceutical Companies Case Studies
Figure 10. Biotechnology Companies Case Studies
Figure 11. Hospitals & Clinics Case Studies
Figure 12. Next Generation Sequencing (NGS) Report Years Considered
Figure 13. Global Next Generation Sequencing (NGS) Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Next Generation Sequencing (NGS) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Next Generation Sequencing (NGS) Market Share by Region: 2022 VS 2033
Figure 16. Global Next Generation Sequencing (NGS) Market Share by Players in 2022
Figure 17. Global Top Next Generation Sequencing (NGS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Sequencing (NGS) as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Next Generation Sequencing (NGS) Revenue in 2022
Figure 19. North America Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Next Generation Sequencing (NGS) Market Share by Type (2018-2033)
Figure 21. North America Next Generation Sequencing (NGS) Market Share by Application (2018-2033)
Figure 22. North America Next Generation Sequencing (NGS) Market Share by Country (2018-2033)
Figure 23. United States Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Next Generation Sequencing (NGS) Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Next Generation Sequencing (NGS) Market Share by Type (2018-2033)
Figure 27. Europe Next Generation Sequencing (NGS) Market Share by Application (2018-2033)
Figure 28. Europe Next Generation Sequencing (NGS) Market Share by Country (2018-2033)
Figure 29. Germany Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Next Generation Sequencing (NGS) Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Next Generation Sequencing (NGS) Market Share by Type (2018-2033)
Figure 37. China Next Generation Sequencing (NGS) Market Share by Application (2018-2033)
Figure 38. Asia Next Generation Sequencing (NGS) Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Next Generation Sequencing (NGS) Market Share by Type (2018-2033)
Figure 40. Asia Next Generation Sequencing (NGS) Market Share by Application (2018-2033)
Figure 41. Asia Next Generation Sequencing (NGS) Market Share by Region (2018-2033)
Figure 42. Japan Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Next Generation Sequencing (NGS) Market Share by Country (2018-2033)
Figure 52. Brazil Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Illumina Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 60. Pacific Biosciences of California Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 61. Beijing Genomics Institute Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 62. Qiagen Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 63. Roche Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 64. Agilent Technologies Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 65. Perkinelmer Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 66. Genomatix Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 67. PierianDx Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 68. Eurofins Scientific Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 69. Gatc Biotech Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 70. Oxford Nanopore Technologies Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 71. Bio-Rad Laboratories Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 72. DNASTAR Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 73. Biomatters Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 74. Partek Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 75. New England Biolabs Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 76. Myriad Genetics Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 77. Macrogen Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed